Pharmacokinetics and bone tissue concentrations of lincomycin following intravenous and intramuscular administrations to cats
- 2 December 2011
- journal article
- clinical trial
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 35 (6) , 534-540
Abstract
Albarellos, G. A., Montoya, L., Denamiel, G. A. A., Velo, M. C., Landoni, M. F. Pharmacokinetics and bone tissue concentrations of lincomycin following intravenous and intramuscular administrations to cats.J. vet. Pharmacol. Therap. 35, 534–540.The pharmacokinetic properties and bone concentrations of lincomycin in cats after single intravenous and intramuscular administrations at a dosage rate of 10 mg/kg were investigated. Lincomycin minimum inhibitory concentration (MIC) for some gram‐positive strains isolated from clinical cases was determined. Serum lincomycin disposition was best‐fitted to a bicompartmental and a monocompartmental open models with first‐order elimination after intravenous and intramuscular dosing, respectively. After intravenous administration, distribution was rapid (T1/2(d) = 0.22 ± 0.09 h) and wide as reflected by the volume of distribution (V(d(ss))) of 1.24 ± 0.08 L/kg. Plasma clearance was 0.28 ± 0.09 L/h·kg and elimination half‐life (T1/2) 3.56 ± 0.62 h. Peak serum concentration (Cmax),Tmax, and bioavailability for the intramuscular administration were 7.97 ± 2.31 μg/mL, 0.12 ± 0.05 h, and 82.55 ± 23.64%, respectively. Thirty to 45 min after intravenous administration, lincomycin bone concentrations were 9.31 ± 1.75 μg/mL. At the same time after intramuscular administration, bone concentrations were 3.53 ± 0.28 μg/mL. The corresponding bone/serum ratios were 0.77 ± 0.04 (intravenous) and 0.69 ± 0.18 (intramuscular). Lincomycin MIC forStaphylococcusspp. ranged from 0.25 to 16 μg/mL and forStreptococcusspp. from 0.25 to 8 μg/mL.Keywords
This publication has 36 references indexed in Scilit:
- Acquired antimicrobial resistance in the intestinal microbiota of diverse cat populationsResearch in Veterinary Science, 2006
- Lack of pharmacokinetic interaction between lincomycin and aspirin in healthy goatsJournal of Veterinary Pharmacology and Therapeutics, 2004
- Passage of lincomycin from blood into the semen of bulls after multiple subcutaneous administration of a lincomycin‐spectinomycin combinationJournal of Veterinary Pharmacology and Therapeutics, 1995
- Comparison of cortical bone and serum concentrations of clindamycin achievable by direct local infusion and intravenous administrationJournal of Orthopaedic Research, 1991
- Tissue concentrations of clindamycin after multiple oral doses in normal catsJournal of Veterinary Pharmacology and Therapeutics, 1990
- Chloramphenicol, lincomycin and oxytetracycline disposition in calves with experimental pneumonic pasteurellosisJournal of Veterinary Pharmacology and Therapeutics, 1986
- Lincomycin Serum and Saliva Concentrations After Intramuscular Injection of High DosesThe Journal of Clinical Pharmacology, 1981
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Estimating the Dimension of a ModelThe Annals of Statistics, 1978
- Comparative pharmacokinetics of thirteen antibiotics in dogsInfection, 1976